This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.
The primary effectiveness objective is to determine if transcutaneous stimulation will generate a respiratory response capable of reducing the extent and duration of oxygen desaturations in patients with presumed risk of obstructive sleep apnea (OSA) who have received some form of anesthesia or sedation. The primary safety objective is the demonstration that the peripheral nerve stimulation is safe for the use of preventing or reducing the sedation related hypoxemic events.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
80
This is a stimulator active device that delivers peripheral nerve stimulation in conjunction with pulse oximetry information.
This is an stimulator sham device that is not providing peripheral nerve stimulation.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Area Under the Curve for oxygen saturation (SpO2%)
Time frame: One hour
Frequency of desaturation episodes
Time frame: One hour
Frequency of nursing interventions
Time frame: One hour
Frequency of Adverse Events
Time frame: 72 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.